Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

355
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
355
Inflammation01:38

Inflammation

57.6K
Overview
57.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

181
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
181
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

111
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

151
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
151
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

145
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
145

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

ENPP1 blockade with a humanized monoclonal antibody enhances renal repair after acute kidney injury.

Cell stem cell·2026
Same author

Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2 complex.

Nucleic acids research·2026
Same author

A liver-heart endocrine axis revealed by systems genetics and mediated by hepatocyte growth factor activator.

medRxiv : the preprint server for health sciences·2026
Same author

p21<sup>+</sup>TREM2<sup>+</sup> senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.

Nature aging·2026
Same author

Novel candidate genes for vestibular function identified through GWAS in the hybrid mouse diversity panel.

BMC genomics·2026
Same author

Genetic factors contributing to atherosclerosis.

Current opinion in cardiology·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
関連記事をすべて見る

関連する実験動画

Updated: Nov 15, 2025

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model
05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

11.4K

動脈硬化 の 悪循環

Aldons J Lusis1

  • 1Departments of Medicine, Microbiology and Human Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Cell
|March 5, 2021
PubMed
まとめ
この要約は機械生成です。

血液細胞の複製により 心臓病のリスクが大きく増加します 動脈硬化の原因である動脈硬化症は 幹細胞の成長を刺激することで この膨張を促すようです

さらに関連する動画

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.2K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.6K

関連する実験動画

Last Updated: Nov 15, 2025

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model
05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

11.4K
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.2K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.6K

科学分野:

  • 心血管科学
  • 血液学
  • 遺伝学

背景:

  • 拡張した体細胞のクローンの存在であるクローナル血液形成 (CH) は,冠動脈疾患 (CHD) のリスクの倍増と関連しています.
  • CHと心血管疾患 (CVD) を結びつける根本的なメカニズムは,まだ完全に理解されていません.

研究 の 目的:

  • 動脈硬化症とクローナル血液形成の関係を調べる
  • 幹細胞の増殖が動脈硬化とCHの関係を媒介する役割を明らかにする.

主な方法:

  • 血液形成幹細胞に対する動脈硬化症の影響を研究するためにマウスモデルを使用した.
  • 拡張クローンを特定し定量化するために 遺伝的配列と系統を追跡した.

主要な成果:

  • 動脈硬化症は骨髄における幹細胞の増殖を著しく増加させることが判明しました.
  • この増加した増殖は,CHの特徴である体細胞クローンの拡大に直接貢献した.
  • この研究は,一般的な心血管疾患とCHの主要な要因を直接的に結びつける証拠を提供します.

結論:

  • 動脈硬化症は幹細胞増殖の重要な刺激であり,クローナル血液形成の発展を促す.
  • この関連性を理解することで,CH患者の心血管疾患を予防するための新しい治療目標が提供されるかもしれません.